BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22042972)

  • 1. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.
    Sun Y; Shen S; Liu X; Tang H; Wang Z; Yu Z; Li X; Wu M
    Mol Cell Biochem; 2014 May; 390(1-2):19-30. PubMed ID: 24402783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression.
    Paterson EL; Kazenwadel J; Bert AG; Khew-Goodall Y; Ruszkiewicz A; Goodall GJ
    Neoplasia; 2013 Feb; 15(2):180-91. PubMed ID: 23441132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
    Wang Z; Yang J; Fisher T; Xiao H; Jiang Y; Yang C
    Environ Health Perspect; 2012 Jan; 120(1):92-7. PubMed ID: 21954225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
    Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis.
    Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
    Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
    Pudova EA; Kudryavtseva AV; Fedorova MS; Zaretsky AR; Shcherbo DS; Lukyanova EN; Popov AY; Sadritdinova AF; Abramov IS; Kharitonov SL; Krasnov GS; Klimina KM; Koroban NV; Volchenko NN; Nyushko KM; Melnikova NV; Chernichenko MA; Sidorov DV; Alekseev BY; Kiseleva MV; Kaprin AD; Dmitriev AA; Snezhkina AV
    BMC Genomics; 2018 Feb; 19(Suppl 3):113. PubMed ID: 29504907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of RNA binding protein, ZFP36L1, promotes epithelial-mesenchymal transition in liver cancer cells by regulating transcription factor ZEB2.
    Chen J; Patial S; Saini Y
    Cell Signal; 2022 Dec; 100():110462. PubMed ID: 36100056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.
    Cheng C; Wan F; Liu L; Zeng F; Xing S; Wu X; Chen X; Zhu Z
    PLoS One; 2014; 9(5):e97406. PubMed ID: 24835085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 3α1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis.
    Villareal LB; Falcon DM; Xie L; Xue X
    Br J Cancer; 2024 May; ():. PubMed ID: 38693428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IKBKE promotes the ZEB2-mediated EMT process by phosphorylating HMGA1a in glioblastoma.
    Sun Y; Guo G; Zhang Y; Chen X; Lu Y; Hong R; Xiong J; Li J; Hu X; Wang S; Liu Y; Zhang Z; Yang X; Nan Y; Huang Q
    Cell Signal; 2024 Apr; 116():111062. PubMed ID: 38242271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
    Yuzhalin AE; Lim SY; Gordon-Weeks AN; Fischer R; Kessler BM; Yu D; Muschel RJ
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G625-G639. PubMed ID: 31545917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine kinase brain overexpression protects colorectal cells from various metabolic and non-metabolic stresses.
    Mooney SM; Rajagopalan K; Williams BH; Zeng Y; Christudass CS; Li Y; Yin B; Kulkarni P; Getzenberg RH
    J Cell Biochem; 2011 Apr; 112(4):1066-75. PubMed ID: 21308735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of VASH2 Inhibits the Stemness and EMT Process by Regulating ZEB2 in Colorectal Cancer.
    Shayimu P; Yin C; Zeng X; Jiapaer R
    Curr Stem Cell Res Ther; 2024; 19(1):126-132. PubMed ID: 37073150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buds, clusters, and transitions in 21st century colorectal carcinoma: revolution or reinvention?
    Feakins RM; Loughrey MB; Silver A
    J Pathol; 2023 Oct; 261(2):121-124. PubMed ID: 37565277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin 6A is expressed at the invasive front and enhances the progression of colorectal cancer.
    Harada-Kagitani S; Kouchi Y; Shinomiya Y; Kodama M; Ohira G; Matsubara H; Ikeda JI; Kishimoto T
    Lab Invest; 2024 May; ():102075. PubMed ID: 38729352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-138 in the regulation of larynx carcinoma cell metastases.
    Gao S; Wang J; Xie J; Zhang T; Dong P
    Tumour Biol; 2015 Oct; ():. PubMed ID: 26499780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orosomucoid 2 upregulation mediates liver injury-induced colorectal cancer liver metastasis by promoting EMT and cell migration.
    Wei X; Wang L; Yang B; Ma Y; Yuan W; Ma J
    Cancer Sci; 2024 Mar; ():. PubMed ID: 38475962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of Cancer Cell Invasion: Are They Good Enough?
    Gerashchenko TS; Novikov NM; Krakhmal NV; Zolotaryova SY; Zavyalova MV; Cherdyntseva NV; Denisov EV; Perelmuter VM
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudobudding: ruptured glands do not represent true tumor buds.
    Haddad TS; van den Dobbelsteen L; Öztürk SK; Geene R; Nijman IJ; Verrijp K; Jamieson NB; Wood C; van Vliet S; Reuvers L; Achouiti S; Rutgers N; Brouwer N; Simmer F; Zlobec I; Lugli A; Nagtegaal ID
    J Pathol; 2023 Sep; 261(1):19-27. PubMed ID: 37403270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.